Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
6.88
+0.54 (8.52%)
At close: Dec 20, 2024, 4:00 PM
6.54
-0.34 (-4.94%)
After-hours: Dec 20, 2024, 5:54 PM EST
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $324.84 million as of December 20, 2024. Its market cap has decreased by -42.38% in one year.
Market Cap
324.84M
Enterprise Value
152.14M
1-Year Change
-42.38%
Ranking
Category
Stock Price
$6.88
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $324.84M, a decrease of -39.66%. That is a compound annual growth rate of -11.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | 610.91M | 13.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sage Therapeutics | 305.87M |
| Nyxoah | 304.33M |
| enGene Holdings | 303.82M |
| Rigel Pharmaceuticals | 303.15M |
| AVITA Medical | 301.35M |
| Aclaris Therapeutics | 296.35M |
| XOMA Royalty | 295.86M |
| Cerus | 293.43M |